Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 25.04.18
Views: 3581

Dr Leena Gandhi - NYU Langone Medical Center, New York, USA

Dr Gandhi presents results at AACR 2018 from a trial assessing the response rate, overall survival and progression free survival of non-squamous non-small cell lung cancer patients treated with a combination of pembrolizumab and chemotherapy.

For more on these results, watch her interview with ecancer.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation